Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,801 | -2,763 | -16,382 | -15,134 | -11,684 |
| Depreciation Amortization | 1,721 | 858 | 3,487 | 2,572 | 1,720 |
| Income taxes - deferred | N/A | N/A | -653 | N/A | N/A |
| Accounts receivable | 3,332 | 1,755 | -5,995 | -2,933 | -2,054 |
| Accounts payable and accrued liabilities | 1,532 | 301 | 556 | -779 | 167 |
| Other Working Capital | 3,985 | 1,350 | -4,247 | -4,798 | -2,537 |
| Other Operating Activity | -3,445 | -1,217 | 11,681 | 8,859 | 5,986 |
| Operating Cash Flow | $-676 | $284 | $-11,553 | $-12,213 | $-8,402 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -15 | -175 | -174 | -123 |
| Investing Cash Flow | $-39 | $-15 | $-175 | $-174 | $-123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 40,000 | 40,000 | 40,000 |
| Debt Repayment | -168 | -110 | -35,327 | -35,268 | -35,187 |
| Common Stock Issued | 26 | N/A | 85 | 51 | 51 |
| Other Financing Activity | 0 | 0 | -3,808 | -3,808 | -3,686 |
| Financing Cash Flow | $-142 | $-110 | $950 | $975 | $1,178 |
| Exchange Rate Effect | -29 | -107 | -248 | -65 | -34 |
| Beginning Cash Position | 13,075 | 13,075 | 24,101 | 24,101 | 24,101 |
| End Cash Position | 12,189 | 13,127 | 13,075 | 12,624 | 16,720 |
| Net Cash Flow | $-886 | $52 | $-11,026 | $-11,477 | $-7,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -676 | 284 | -11,553 | -12,213 | -8,402 |
| Capital Expenditure | -39 | -15 | -175 | -174 | -123 |
| Free Cash Flow | -715 | 269 | -11,728 | -12,387 | -8,525 |